How To Use CPT Code 90673

CPT 90673 describes the administration of a trivalent influenza virus vaccine derived from recombinant DNA, specifically the hemagglutinin (HA) protein, into the muscle of a patient. This article will cover the description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, similar codes and billing examples.

1. What is CPT Code 90673?

CPT 90673 is used to describe the administration of a trivalent influenza virus vaccine derived from recombinant DNA, specifically the hemagglutinin (HA) protein, into the muscle of a patient. This vaccine is preservative and antibiotic-free, and it is given through an intramuscular injection.

2. Official Description

The official description of CPT code 90673 is: ‘Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use.’

3. Procedure

1. The healthcare provider discusses the benefits and risks of the influenza virus vaccine with the patient.
2. The provider administers the vaccine through an intramuscular injection into the patient’s muscle.
3. After administering the vaccine, the provider explains the aftercare procedures to the patient.

4. Qualifying circumstances

CPT 90673 is used for patients who require immunization against the influenza virus. The vaccine is specifically derived from recombinant DNA, focusing on the hemagglutinin (HA) protein. It is important to note that the vaccine is preservative and antibiotic-free. The administration of the vaccine should be performed by a qualified healthcare provider.

5. When to use CPT code 90673

CPT code 90673 should be used when a patient receives the trivalent influenza virus vaccine derived from recombinant DNA, specifically the hemagglutinin (HA) protein, through an intramuscular injection. It is important to ensure that the vaccine is preservative and antibiotic-free.

6. Documentation requirements

To support a claim for CPT 90673, the healthcare provider must document the following information:

• Administration of the trivalent influenza virus vaccine derived from recombinant DNA
• Specific focus on the hemagglutinin (HA) protein
• Preservative and antibiotic-free nature of the vaccine
• Date and time of administration
• Route of administration (intramuscular)
• Signature of the healthcare provider administering the vaccine

7. Billing guidelines

When billing for CPT 90673, ensure that the vaccine is administered by a qualified healthcare provider and that it is given through an intramuscular injection. It is important to follow the specific guidelines for reporting CPT 90673 and to include the necessary documentation to support the claim. Additionally, consider any additional tips provided by the payer or coding guidelines to accurately report the vaccine administration.

8. Historical information

CPT 90673 was added to the Current Procedural Terminology system on January 1, 2014. There have been no updates or changes to the code since its addition.

9. Examples

1. A healthcare provider administers the trivalent influenza virus vaccine derived from recombinant DNA, focusing on the hemagglutinin (HA) protein, to a patient through an intramuscular injection.
2. A nurse administers the preservative and antibiotic-free influenza virus vaccine to a patient, ensuring the proper administration technique.
3. A physician discusses the benefits and risks of the trivalent influenza virus vaccine with a patient before administering it through an intramuscular injection.
4. A healthcare provider documents the administration of the influenza virus vaccine, including the specific focus on the hemagglutinin (HA) protein and the preservative and antibiotic-free nature of the vaccine.
5. A nurse signs off on the administration of the trivalent influenza virus vaccine, ensuring that all necessary documentation is complete.
6. A healthcare provider follows the billing guidelines for reporting CPT 90673, accurately documenting the administration of the vaccine and any additional information required by the payer.
7. A pharmacist prepares the trivalent influenza virus vaccine derived from recombinant DNA, ensuring that it is preservative and antibiotic-free.
8. A healthcare provider educates a patient on the importance of receiving the influenza virus vaccine and addresses any concerns or questions the patient may have.
9. A nurse administers the trivalent influenza virus vaccine to a patient, following all safety protocols and guidelines.
10. A healthcare provider schedules follow-up appointments to ensure that the patient receives the necessary booster doses of the influenza virus vaccine.